Pancretec, a manufacturer of ambulatory drug-delivery systems,...

Pancretec, a manufacturer of ambulatory drug-delivery systems, reported a second-quarter net loss of $34,140 on sales of $1.3 million, compared with a loss of $161,516 on sales of $755,150 for the same quarter last year.

Although Pancretec posted its second consecutive quarterly operating profit, a net loss was created by payments to holders of preferred stock, President James Yarter said Wednesday.

For the six months ended Dec. 31, Pancretec reported a net loss of $89,018 on sales of $2.4 million, compared to a net loss of $453,957 on sales of $1.25 million over the same six months a year ago.